GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 54 filers reported holding GENERATION BIO CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,853 | -43.4% | 3,919 | -17.9% | 0.00% | – |
| Q2 2023 | $26,244 | +28.1% | 4,776 | 0.0% | 0.00% | – |
| Q1 2023 | $20,489 | -74.5% | 4,776 | -76.6% | 0.00% | – |
| Q4 2022 | $80,357 | -19.6% | 20,447 | +7.8% | 0.00% | – |
| Q3 2022 | $100,000 | -11.5% | 18,969 | +10.5% | 0.00% | – |
| Q2 2022 | $113,000 | -8.1% | 17,164 | +2.8% | 0.00% | – |
| Q1 2022 | $123,000 | +5.1% | 16,689 | +1.0% | 0.00% | – |
| Q4 2021 | $117,000 | -71.7% | 16,522 | 0.0% | 0.00% | – |
| Q3 2021 | $414,000 | +63.0% | 16,522 | +75.3% | 0.00% | – |
| Q2 2021 | $254,000 | -1.2% | 9,427 | +4.1% | 0.00% | – |
| Q1 2021 | $257,000 | +394.2% | 9,056 | +397.9% | 0.00% | – |
| Q4 2020 | $52,000 | +23.8% | 1,819 | +33.2% | 0.00% | – |
| Q3 2020 | $42,000 | -88.4% | 1,366 | -92.1% | 0.00% | – |
| Q2 2020 | $362,000 | – | 17,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |